CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.08
0.92%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Lexicon Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.09
Open* 1.08
1-Year Change* -47.57%
Day's Range* 1.05 - 1.08
52 wk Range 0.92-3.79
Average Volume (10 days) 2.91M
Average Volume (3 months) 51.51M
Market Cap 264.52M
P/E Ratio -100.00K
Shares Outstanding 244.93M
Revenue 531.00K
EPS -0.76
Dividend (Yield %) N/A
Beta 1.07
Next Earnings Date Feb 29, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 28, 2023 1.08 -0.02 -1.82% 1.10 1.10 1.05
Nov 27, 2023 1.09 0.01 0.93% 1.08 1.11 1.06
Nov 24, 2023 1.10 -0.01 -0.90% 1.11 1.14 1.08
Nov 22, 2023 1.08 0.01 0.93% 1.07 1.12 1.07
Nov 21, 2023 1.06 -0.06 -5.36% 1.12 1.14 1.06
Nov 20, 2023 1.15 0.05 4.55% 1.10 1.17 1.10
Nov 17, 2023 1.09 0.03 2.83% 1.06 1.09 1.04
Nov 16, 2023 1.04 -0.03 -2.80% 1.07 1.08 1.02
Nov 15, 2023 1.10 -0.01 -0.90% 1.11 1.22 1.09
Nov 14, 2023 1.09 0.02 1.87% 1.07 1.13 1.05
Nov 13, 2023 1.04 0.05 5.05% 0.99 1.04 0.91
Nov 10, 2023 0.98 -0.03 -2.97% 1.01 1.01 0.89
Nov 9, 2023 1.01 -0.09 -8.18% 1.10 1.12 1.01
Nov 8, 2023 1.11 0.00 0.00% 1.11 1.21 1.08
Nov 7, 2023 1.22 -0.03 -2.40% 1.25 1.25 1.21
Nov 6, 2023 1.25 -0.22 -14.97% 1.47 1.47 1.25
Nov 3, 2023 1.45 0.09 6.62% 1.36 1.47 1.36
Nov 2, 2023 1.37 0.05 3.79% 1.32 1.37 1.24
Nov 1, 2023 1.30 0.08 6.56% 1.22 1.30 1.18
Oct 31, 2023 1.21 0.05 4.31% 1.16 1.23 1.13

Lexicon Events

Time (UTC) Country Event
Thursday, November 30, 2023

Time (UTC)

14:30

Country

US

Event

Lexicon Pharmaceuticals Inc at Piper Sandler Healthcare Conference
Lexicon Pharmaceuticals Inc at Piper Sandler Healthcare Conference

Forecast

-

Previous

-
Thursday, February 29, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Lexicon Pharmaceuticals Inc Earnings Release
Q4 2023 Lexicon Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

13:00

Country

US

Event

Lexicon Pharmaceuticals Inc Annual Shareholders Meeting
Lexicon Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0.139 0.298 23.995 322.073 63.209
Revenue 0.139 0.298 23.995 322.073 63.209
Cost of Revenue, Total 0 0 1.929 3.231 2.491
Gross Profit 0.139 0.298 22.066 318.842 60.718
Total Operating Expense 100.899 87.388 70.792 180.628 166.488
Selling/General/Admin. Expenses, Total 48.083 32.342 47.23 56.835 63.754
Research & Development 52.816 55.046 153.621 91.924 100.243
Other Operating Expenses, Total 0 0
Operating Income -100.76 -87.09 -46.797 141.445 -103.279
Interest Income (Expense), Net Non-Operating -2.78 -0.802 -14.544 -20.676 -20.777
Other, Net 1.596 0.134 2.767 3.35 3.508
Net Income Before Taxes -101.944 -87.758 -58.574 124.119 -120.548
Net Income After Taxes -101.944 -87.758 -58.574 130.133 -120.548
Net Income Before Extra. Items -101.944 -87.758 -58.574 130.133 -120.548
Net Income -101.944 -87.758 -58.574 130.133 -120.548
Income Available to Common Excl. Extra. Items -101.944 -87.758 -58.574 130.133 -120.548
Income Available to Common Incl. Extra. Items -101.944 -87.758 -58.574 130.133 -120.548
Diluted Net Income -101.944 -87.758 -58.574 130.133 -120.548
Diluted Weighted Average Shares 165.733 145.652 110.841 116.747 105.83
Diluted EPS Excluding Extraordinary Items -0.61511 -0.60252 -0.52845 1.11466 -1.13907
Diluted Normalized EPS -0.61511 -0.60252 -1.71924 1.2741 -1.13907
Total Extraordinary Items 0
Unusual Expense (Income) 0 0 -131.988 28.638
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0.317 0.024 0.028 0.039 0.035
Revenue 0.317 0.024 0.028 0.039 0.035
Cost of Revenue, Total 0.008
Gross Profit 0.309
Total Operating Expense 44.557 31.166 30.306 23.134 24.042
Selling/General/Admin. Expenses, Total 30.008 19.14 16.329 12.577 10.686
Research & Development 14.541 12.026 13.977 10.557 13.356
Operating Income -44.24 -31.142 -30.278 -23.095 -24.007
Interest Income (Expense), Net Non-Operating -1.96 -1.821 -1.103 -0.864 -0.703
Other, Net 1.296 1.029 0.887 0.572 0.123
Net Income Before Taxes -44.904 -31.934 -30.494 -23.387 -24.587
Net Income After Taxes -44.904 -31.934 -30.494 -23.387 -24.587
Net Income Before Extra. Items -44.904 -31.934 -30.494 -23.387 -24.587
Net Income -44.904 -31.934 -30.494 -23.387 -24.587
Income Available to Common Excl. Extra. Items -44.904 -31.934 -30.494 -23.387 -24.587
Income Available to Common Incl. Extra. Items -44.904 -31.934 -30.494 -23.387 -24.587
Diluted Net Income -44.904 -31.934 -30.494 -23.387 -24.587
Diluted Weighted Average Shares 204.783 189.014 188.98 174.904 149.616
Diluted EPS Excluding Extraordinary Items -0.21928 -0.16895 -0.16136 -0.13371 -0.16433
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.21928 -0.16895 -0.16136 -0.13371 -0.16433
Unusual Expense (Income) 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 140.866 88.921 157.719 337.754 173.324
Cash and Short Term Investments 138.357 86.743 152.275 271.659 160.052
Cash & Equivalents 46.345 64.065 126.263 36.112 80.386
Short Term Investments 92.012 22.678 26.012 235.547 79.666
Total Receivables, Net 0.028 0.014 0.395 56.532 5.924
Accounts Receivable - Trade, Net 0.028 0.014 0.395 56.532 5.924
Prepaid Expenses 2.481 2.164 5.049 5.32 2.668
Total Assets 194.299 136.909 203.788 417.715 284.136
Property/Plant/Equipment, Total - Net 4.371 3.476 1.495 15.747 15.865
Property/Plant/Equipment, Total - Gross 8.355 8.329 7.31 77.488 75.871
Accumulated Depreciation, Total -3.984 -4.853 -5.815 -61.741 -60.006
Goodwill, Net 44.543 44.543 44.543 44.543 44.543
Intangibles, Net 0 19.716 50.119
Other Long Term Assets, Total 4.519 -0.031 0.031 -0.045 0.285
Total Current Liabilities 23.172 22.124 46.806 65.341 36.751
Accounts Payable 10.395 9.152 5.469 12.178 17.759
Accrued Expenses 12.373 10.469 29.691 42.151 14.482
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 11.646 11.012 1.115
Other Current Liabilities, Total 0.404 2.503 0 3.395
Total Liabilities 77.175 23.314 47.417 300.614 310.541
Total Long Term Debt 48.579 0 0 234.171 243.887
Long Term Debt 48.579 0 234.171 243.887
Deferred Income Tax 0 6.014
Other Liabilities, Total 5.424 1.19 0.611 1.102 23.889
Total Equity 117.124 113.595 156.371 117.101 -26.405
Common Stock 0.189 0.15 0.142 0.106 0.106
Additional Paid-In Capital 1709.14 1608.75 1561.1 1462.17 1447.95
Retained Earnings (Accumulated Deficit) -1589.72 -1487.78 -1400.02 -1341.44 -1471.58
Treasury Stock - Common -2.061 -7.518 -4.843 -3.817 -2.876
Other Equity, Total -0.428 -0.01 -0.006 0.084 -0.012
Total Liabilities & Shareholders’ Equity 194.299 136.909 203.788 417.715 284.136
Total Common Shares Outstanding 188.726 148.917 141.496 106.272 105.926
Total Inventory 0 4.243 4.68
Redeemable Preferred Stock 0 0 0 0 0
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 223.372 263.72 109.546 140.866 139.063
Cash and Short Term Investments 218.427 256.739 105.937 138.357 136.203
Cash & Equivalents 21.116 102.271 26.001 46.345 18.834
Short Term Investments 197.311 154.468 79.936 92.012 117.369
Total Receivables, Net 0.318 0.685 0.261 0.028 0.039
Accounts Receivable - Trade, Net 0.318 0.685 0.261 0.028 0.039
Prepaid Expenses 4.291 6.124 3.348 2.481 2.821
Total Assets 276.479 316.724 162.716 194.299 191.685
Property/Plant/Equipment, Total - Net 7.821 8.461 8.627 4.371 8.032
Property/Plant/Equipment, Total - Gross 6.525 6.442 6.303 8.355 6.109
Accumulated Depreciation, Total -4.391 -4.24 -4.096 -3.984 -5.177
Goodwill, Net 44.543 44.543 44.543 44.543 44.543
Other Long Term Assets, Total 0.743 4.519 0.047
Total Current Liabilities 32.261 26.109 20.371 23.172 18.445
Accounts Payable 12.036 10.501 10.311 10.395 9.427
Accrued Expenses 19.654 14.928 9.576 12.373 8.299
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Total Liabilities 136.969 130.363 74.67 77.175 47.667
Total Long Term Debt 99.265 98.772 48.845 48.579 23.784
Other Liabilities, Total 5.443 5.482 5.454 5.424 5.438
Total Equity 139.51 186.361 88.046 117.124 144.018
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.245 0.245 0.19 0.189 0.189
Additional Paid-In Capital 1859.35 1855.66 1712.56 1709.14 1705.61
Retained Earnings (Accumulated Deficit) -1717.08 -1666.56 -1621.65 -1589.72 -1559.23
Treasury Stock - Common -2.885 -2.885 -2.885 -2.061 -2.061
Other Equity, Total -0.113 -0.1 -0.163 -0.428 -0.491
Total Liabilities & Shareholders’ Equity 276.479 316.724 162.716 194.299 191.685
Total Common Shares Outstanding 244.925 244.925 189.562 188.726 188.726
Other Current Liabilities, Total 0.571 0.68 0.484 0.404 0.719
Long Term Debt 99.265 98.772 48.845 48.579 23.784
Total Inventory 0.336 0.172
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -101.944 -87.758 -58.574 130.133 -120.548
Cash From Operating Activities -88.851 -87.017 -142.969 113.807 -148.607
Cash From Operating Activities 0.427 0.292 2.934 3.654 3.683
Deferred Taxes 0 0 -6.014 0
Non-Cash Items 12.264 10.68 -118.408 44.321 13.032
Cash Interest Paid 2.289 0.799 17.353 19.211 16.465
Changes in Working Capital 0.402 -10.231 31.079 -58.287 -44.774
Cash From Investing Activities -71.078 2.11 380.756 -155.855 169.576
Capital Expenditures -1.326 -1.221 -0.087 -0.07 -0.095
Other Investing Cash Flow Items, Total -69.752 3.331 380.843 -155.785 169.671
Cash From Financing Activities 142.209 22.709 -147.636 -2.226 -2.244
Issuance (Retirement) of Stock, Net 93.341 34.409 68.944 -0.941 -0.24
Issuance (Retirement) of Debt, Net 48.868 -11.7 -216.58 -1.285 -2.004
Net Change in Cash -17.72 -62.198 90.151 -44.274 18.725
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -31.934 -101.944 -71.45 -48.063 -23.476
Cash From Operating Activities -31.613 -88.851 -67.282 -47.843 -23.421
Cash From Operating Activities 0.112 0.427 0.324 0.216 0.109
Non-Cash Items 3.68 12.264 8.648 5.783 2.797
Cash Interest Paid 1.556 2.289 1.281 0.634 0.085
Changes in Working Capital -3.471 0.402 -4.804 -5.779 -2.851
Cash From Investing Activities 12.093 -71.078 -95.252 -18.056 -4.408
Capital Expenditures -0.248 -1.326 -0.08 -0.076 -0.076
Other Investing Cash Flow Items, Total 12.341 -69.752 -95.172 -17.98 -4.332
Cash From Financing Activities -0.824 142.209 117.303 23.284 23.284
Issuance (Retirement) of Stock, Net -0.824 93.341 93.404 -0.864 -0.864
Issuance (Retirement) of Debt, Net 0 48.868 23.899 24.148 24.148
Net Change in Cash -20.344 -17.72 -45.231 -42.615 -4.545
Deferred Taxes
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Artal International S.C.A. Investment Advisor 46.5601 114037070 27775050 2023-06-30 HIGH
BVF Partners L.P. Hedge Fund 8.1639 19995332 3846153 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.475 8511068 3270821 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.6274 6435051 1142425 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.3344 5717576 654600 2023-06-30 LOW
Ulys, L.L.C. Investment Advisor 2.2257 5451204 0 2023-06-05 LOW
Invus Public Equities Advisors, LLC Investment Advisor 1.4356 3516214 0 2023-06-30 MED
JP Morgan Asset Management Investment Advisor 1.0966 2685941 -362433 2023-06-30 LOW
Millennium Management LLC Hedge Fund 1.0755 2634173 2610329 2023-06-30 HIGH
New Enterprise Associates (NEA) Venture Capital 0.9727 2382286 0 2023-06-30 LOW
Octagon Capital Advisors LP Hedge Fund 0.7852 1923076 1923076 2023-06-30 MED
Pinnacle Associates Ltd. Investment Advisor/Hedge Fund 0.781 1912869 -80758 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7514 1840437 115028 2023-06-30 LOW
Alyeska Investment Group, L.P. Hedge Fund 0.7114 1742352 1742352 2023-06-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.7064 1730112 166014 2023-06-30 LOW
Debbane (Raymond) Individual Investor 0.5475 1340847 1000000 2023-10-12 LOW
Parkman Healthcare Partners LLC Hedge Fund 0.5433 1330616 655288 2023-06-30
D. E. Shaw & Co., L.P. Hedge Fund 0.4956 1213726 -1727271 2023-06-30 MED
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.3423 838408 838408 2023-06-30 LOW
Coats Lonnel Individual Investor 0.3325 814359 70000 2023-06-29 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Lexicon Company profile

Lexicon
Industry: Bio Therapeutic Drugs

8800 Technology Forest Place
8800 Technology Forest Place
THE WOODLANDS
TEXAS 77381
US

Income Statement

  • Annual
  • Quarterly

News

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

Gold Rises as Traders price-in Fed Rate Cuts

Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

13:17, 20 November 2023

People also watch

Gold

2,038.93 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

0.62 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

38,189.85 Price
+0.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

16,075.70 Price
+0.430% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading